Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant. 2002

Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
Central Institute for Animal Disease Control, CIDC-Lelystad, PO Box 2004, Houtribweg 39, NL 8203 AA Lelystad, The Netherlands. e.m.a.vanrooij@id.wag-ur.nl

To enhance the efficacy of a DNA vaccine against pseudorabies virus (PRV), we evaluated the adjuvant properties of plasmids coding for gamma interferon or interleukin-12, of CpG immunostimulatory motifs, and of the conventional adjuvants dimethyldioctadecylammonium bromide in water (DDA) and sulfolipo-cyclodextrin in squalene in water. We demonstrate that a DNA vaccine combined with DDA, but not with the other adjuvants, induced significantly stronger immune responses than plasmid vaccination alone. Moreover, pigs vaccinated in the presence of DDA were protected against clinical disease and shed significantly less PRV after challenge infection. This is the first study to demonstrate that DDA, a conventional adjuvant, enhances DNA vaccine-induced antiviral immunity.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D011557 Pseudorabies A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals. Aujeszky's Disease,Aujeszky Disease,Aujeszkys Disease
D011558 Herpesvirus 1, Suid A species of VARICELLOVIRUS producing a respiratory infection (PSEUDORABIES) in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink. Aujeszky's Disease Virus,Swine Herpesvirus 1,Aujeszky Disease Virus,Herpesvirus 1 (alpha), Suid,Herpesvirus Suis,Pseudorabies Virus,Suid Herpesvirus 1,Aujeszkys Disease Virus,Herpesvirus 1, Swine,Pseudorabies Viruses,Virus, Pseudorabies,Viruses, Pseudorabies
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000644 Quaternary Ammonium Compounds Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN Quaternary Ammonium Compound,Ammonium Compound, Quaternary,Ammonium Compounds, Quaternary,Compound, Quaternary Ammonium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
July 2001, Vaccine,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
February 1980, Cellular immunology,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
July 2001, Virology,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
September 2006, Biochemical and biophysical research communications,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
January 2000, Vaccine,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
April 2001, Vaccine,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
July 2009, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
March 2015, International immunopharmacology,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
January 2006, Microbiology and immunology,
Eugene M A van Rooij, and Harrie L Glansbeek, and Luuk A T Hilgers, and Eddie G te Lintelo, and Yolanda E de Visser, and Wim J A Boersma, and Bart L Haagmans, and Andre T J Bianchi
November 2014, Molecular medicine reports,
Copied contents to your clipboard!